Your browser doesn't support javascript.
loading
Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells.
Pérez-Cárdenas, Enrique; Taja-Chayeb, Lucía; Trejo-Becerril, Catalina; Chanona-Vilchis, José; Chávez-Blanco, Alma; Domínguez-Gómez, Guadalupe; Langley, Elizabeth; García-Carrancá, Alejandro; Dueñas-González, Alfonso.
Afiliação
  • Pérez-Cárdenas E; Division of Basic Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Taja-Chayeb L; Division of Basic Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Trejo-Becerril C; Division of Basic Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Chanona-Vilchis J; Department of Pathology, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Chávez-Blanco A; Division of Basic Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Domínguez-Gómez G; Division of Basic Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • Langley E; Division of Basic Research, Instituto Nacional de Cancerología, Mexico City, Mexico.
  • García-Carrancá A; Unit of Biomedical Research on Cancer, Biomedical Research Institute, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico, alfonso_duenasg@yahoo.com.
  • Dueñas-González A; Unit of Biomedical Research on Cancer, Instituto Nacional de Cancerologia, Mexico City, Mexico, alfonso_duenasg@yahoo.com.
Onco Targets Ther ; 11: 8823-8833, 2018.
Article em En | MEDLINE | ID: mdl-30584338

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2018 Tipo de documento: Article País de afiliação: México

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Onco Targets Ther Ano de publicação: 2018 Tipo de documento: Article País de afiliação: México